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The  cytotoxicity  of  quercetin  is not  well  understood.  Using  an  ICR murine  model,  we
unexpectedly  found  that mice  exposed  to 7 Gy  total  body  irradiation  (TBI)  exhibited  gen-
eral in vivo  toxicity  after  receiving  quercetin  (100 mg/kg  PO),  whereas  this  result  was  not
observed  in mice  that  received  TBI only.  In order to understand  the  involvement  of  alter-
ations  in mitochondrial  biogenesis,  we  used  a real-time  qPCR  to analyze  the mitochondrial
DNA  copy  number  (mtDNAcn)  by amplifying  the  MTRNR1  (12S  rRNA)  gene  in  murine  bone
marrow.  We  also  utilized  reverse  transcription  qPCR  to  determine  the  mRNA  amounts
transcribed  from  the  polymerase  gamma  (POLG),  POLG2,  and  mammalian  mitochondrial
transcription  factor  A  (TFAM)  genes  in the  tissue.  In the mice exposed  to  TBI  combined  with
quercetin,  we found:  (1)  the  radiation-induced  increase  of mtDNAcn  was  inhibited  with  a
concurrent  signiﬁcant  decrease  in  POLG  expression;  (2)  TFAM  expression  was  signiﬁcantlyMitochondrial DNA copy number
POLG
POLG2
TFAM
increased;  and  (3)  the  expression  of  POLG2  was not  inﬂuenced  by  the  treatments.  These
data  suggest  that  the overall  toxicity  was  in  part  associated  with  the  decrease  in mtDNAcn,
an  effect  apparently  caused  by the inhibition  of POLG  expression  and  overexpression  of
TFAM; unaltered  POLG2  expression  did  not  seem  to contribute  to  toxicity.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  B
1. Introduction
Many natural components in our diet have a wide vari-
ety  of beneﬁcial health effects and are widely consumed
by the general population [1–3]. Epidemiological studies
have  found that an increased intake of dietary ﬂavonoids
is  associated with a decreased risk of chronic diseases,
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including certain cancers and cardiovascular diseases
[4–6]. Quercetin, one such ﬂavonoid ubiquitously present
in  various vegetables, fruits, seeds, nuts, tea, and
red wine, has received considerable attention due to
its  antiproliferative, chemopreventive, anti-inﬂammatory,
and anticarcinogenic activities and gene expression-
modulating potential [7,8]. However, studies have also
shown  that quercetin has potentially toxic effects, includ-
ing  its mutagenicity, prooxidant activity, mitochondrial
toxicity, and inhibition of key enzymes involved in hor-
mone  metabolism [9,10]. Such scientiﬁc uncertainty has
is is an open access article under the CC BY-NC-ND license
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rompted further investigations of the pharmacological
roperties of quercetin to better ascertain its safety as a
ietary  supplement.
Since  numerous studies have reported that quercetin
ossesses strong antioxidant properties, we recently car-
ied  out a study to compare the radioprotective effects of a
ew  other natural potential antioxidants, such as curcumin
nd  resveratrol, with quercetin on ICR mice exposed to 7 Gy
otal  body irradiation (TBI). We  unexpectedly observed that
ice  exposed to TBI in combination with quercetin dis-
layed  more severe overall health status and weight loss
han  the mice that only received TBI. Considering the estab-
ished  roles of mitochondria in the metabolism of reactive
xygen species (ROS), the extensively described antiox-
dant  and pro-oxidant properties of quercetin, and the
nding  that mitochondria can accumulate large amounts
f  quercetin [11], we speculated that mitochondria-related
hanges might be associated with the observed toxicity.
This  paper reports the effects of quercetin on mitochon-
rial DNA copy number (mtDNAcn) and the concurrent
xpression alterations of 3 key factors involved in mito-
hondrial replication, polymerase gamma  (POLG), POLG2,
nd  mammalian mitochondrial transcription factor A
TFAM).  Polg and Polg2 are 2 subunits that constitute
he mitochondria-speciﬁc DNA polymerase gamma  (Pol),
hich  is the only polymerase responsible for mtDNA repli-
ation.  Tfam is a protein that triggers mtDNA transcription
nd is a necessary component for the initiation of mtDNA
eplication in mammals [12]. In light of the ﬁnding that
n  increase in mtDNAcn is a compensatory response after
rradiation [13–15], we reasoned that the harmful effects of
uercetin  on mice could be associated with the repression
f  mtDNAcn and the accompanying expression changes in
he  key factors related to mtDNA anabolism.
. Materials and methods
.1.  Chemicals and solutions
Quercetin  was purchased from Sigma (St. Louis, MO).
latinum SYBR Green qPCR SuperMix-UDG, M-MLV  First
trand  cDNA synthesis kit, and TRIzol reagent were
btained from Invitrogen (Grand Island, NY). All other
hemicals were reagent grade or the highest available
rade and were purchased from commercial vendors.
.2.  Animals and treatments
Since  in most species, including humans, mtDNA is
aternally inherited, and studies have shown that female
ice  are more sensitive than male mice to mitochondrial
oxicities when the animals are exposed to chemicals [16],
ur  present study thus only used female ICR mice (8–10
eeks old). They were divided into groups of 6 mice. Nor-
al  control mice were not irradiated. Mice in the irradiated
roups were immobilized with the aid of a plastic restrainer
nd  received a single dose of 7 Gy TBI via a 6 MV  X-ray
ource (600 CD Accelerator, Varian Oncology Systems, Palo
lto,  CA) at the dose rate of 400 MU/min with a homo-
eneity of ±3.0%. One hour after irradiation, mice were
avaged with quercetin dissolved in physiological saline (arts 1 (2014) 450–458 451
volume  of 0.02 ml/g body weight after well suspension so
as  to deliver 100 mg/kg body weight) or with the same unit
volume  of saline. Mice were maintained in a temperature-
controlled room with a 12-h light/dark cycle and provided
with  standard laboratory chow and tap water ad libitum.
Mice were weighed one day before irradiation and every
other  day after exposure. They were euthanized 17 days
after  treatment. Bone tissues were rapidly dissected on ice
and  collected into vials after soft tissues were removed. The
collected  bone marrow tissues were frozen immediately
at −70 ◦C until use. All procedures involving animals were
in  accordance with protocols established by the World
Health Organization and the Chinese National Science
Academy.
2.3. DNA extraction from mouse tissues
Total DNA was extracted from the stored bone mar-
row tissues by standard proteolytic digestion followed
by phenol/chloroform/isoamyl alcohol puriﬁcation. To
extract  the DNA, the bone marrow tissues were ﬁrst
crushed by repetitive strikes with a hammer immedi-
ately after they underwent snap-freezing in liquid nitrogen
vapor  in a clean, disposable plastic bag. Absorbance at
260  nm was  used for quantiﬁcation of the extracted
DNA.
2.4. RNA extraction from mouse tissues and cDNA
synthesis
After bone marrow tissues were crushed (as described
above), TRIzol reagent was used to extract the total RNA,
and  the RNA pellet from each sample was dissolved
in diethylpyrocarbonate (DEPC) water at approximately
1 ng/l. Reverse transcription PCR was  performed with a
M-MLV  First Strand cDNA synthesis kit, according to man-
ufacturer’s instructions, using oligo(dT)20 as a primer.
2.5. Primer design
The 2 oligonucleotide PCR primers for detecting the
MTRNR1 (12S rRNA) gene of the murine mitochondrial
genome were designed based on GenBank nucleotide
sequence NC 005089.1, Mus  musculus domesticus mito-
chondrion. The sequences for the primers were 5′-ACC
GCG  GTC ATA CGA TTA AC-3′ (forward) and 5′-CCC AGT
TTG  GGT CTT AGC TG-3′ (reverse). They directed the syn-
thesis  of the 177-bp mtDNA fragment from an mtDNA
region in which deletions are rare. As such, alterations
in mtDNA content or copy number in cells could be
detected quantitatively by comparing them to a nuclear-
encoded housekeeping gene. The housekeeping gene used
for  this purpose was  the mouse nuclear 18S rRNA gene.
The  primer sequences amplifying this housekeeping gene
were  designed based on GeneBank sequence BK000964.3,
Mus  musculus 18SrRNA. Their sequences were 5′-CGC GGT
TCT  ATT TTG TTG GT-3′ (forward) and 5′-AGT CGG CAT
CGT  TTA TGG TC-3′ (reverse), producing a 219-bp prod-
uct.  The primers for detecting POLG gene expression were
designed based on GeneBank sequence BC061472.1, Mus
musculus POLG cDNA. Their sequences were 5′-AGA AGC
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Fig. 1. Changes in body weight of mice administered quercetin. Mice
received intraperitoneal injections of amifostine dissolved in physiologi-
cal saline (a volume of 0.02 ml/g body weight to deliver 200 mg/kg body
weight) 30 min  before irradiation or were orally administered quercetin
1 h after 7 Gy TBI, then observed for 17 days for body weight changes and452 R. Chen et al. / Toxicolo
AGA GCC TGC CTT AC-3′ (forward) and 5′-CTC TGC CAA GCA
GAC  CTC C-3′(reverse), which produced a 125-bp ampli-
con.  The primers for determining POLG2 gene expression
were designed based on GeneBank sequence NM 015810.1,
Mus  musculus POLG2 cDNA. Their sequences were 5′-CTT
GCA  AGA CAG AGA GCC G-3′ (forward) and 5′-CTG GGT
GTC  TGA TTG CTG TTC-3′ (reverse), which resulted in a
210-bp  PCR product. The sequences of the primers ampli-
fying  the murine TFAM cDNA were 5′-GGA ATG TGG AGC
GTG  CTA AAA-3′ (forward) and 5′-TGC TGG AA A AAC ACT
TCG  GAA TA-3′(reverse); these were chosen from a pub-
lication [17], and they produced a 118-bp amplicon. The
ACTB  gene was  used as an internal control for quantify-
ing the transcription levels of these genes, and the primers
were designed based on GeneBank sequence NM 007393.3,
Mus  musculus ATCB cDNA. Their sequences were 5′-GAA
GGA  CTC CTA TGT GGG TGA C-3′ (forward) and 5′-TTC ACG
GTT  GGC CTT AGG-3′ (reverse), which produced a 205-bp
product.
2.6. Gene ampliﬁcation and quantiﬁcation by real-time
quantitative PCR (qPCR)
Real-time  qPCR was performed using a combination
of the 2 primers noted above and the extracted genomic
DNA or synthesized cDNA as the DNA template sources.
The total volume of the qPCR mixture was 20 l, consist-
ing  of 2× PlatinumSYBR Green qPCR SuperMix-UDG (1×
ﬁnal),  0.5 M of each oligonucleotide primer, and 1–3 l
of  the genomic DNA or cDNA template source. Each reac-
tion  was subjected to an initial denaturation of 5 min  at
95 ◦C, followed by 40 ampliﬁcation cycles of denaturation
at 95 ◦C for 30 s and combined annealing and extension at
60 ◦C for 1 min  on an Applied Biosystems7500 real-time
PCR detection system. Preliminary conventional PCR and
qPCR  were ﬁrst run to develop qPCR conditions using the
same  primers. All the qPCRs were run in duplicate and
repeated at least twice to eliminate technical bias after
averaging the obtained cycle number (Ct) data. The Ct was
the  cycle number at which the ﬂuorescent signal of a given
reaction well crossed the threshold value and was used
as  a basis for quantiﬁcation of mtDNA and nuclear DNA
(nDNA) copy numbers as well as gene expression proﬁles.
Under the assumption of equal efﬁciencies during qPCR
ampliﬁcations, the difference in Ct resulting from the differ-
ent  reactions was calculated to estimate the mtDNA:nDNA
ratio and to normalize the gene expression levels using
2−Ct and 2−Ct mathematical models [18,19].
2.7.  Data analysis
The  data were expressed as mean ± SE and plotted with
Microsoft Excel (Microsoft Corporation, Redmond, WA)
and  the GraphPad Prism 5 statistical package (GraphPad
Software, Inc., La Jolla, CA). When appropriate, analysis
of  variance (ANOVA) was ﬁrst performed by using the
package to ascertain whether there were signiﬁcant differ-
ences  among the multiple means; the data were scrutinized
further by performing unpaired two-tailed t tests. The sig-
niﬁcance  level was set at P < 0.05.survival. Data represented are the mean ± SE of 6 animals per treatment
and time point. # represents the death of one mouse in the group at the
time indicated.
3. Results
3.1. Body weight changes in mice
Fig. 1 shows the changes in body weight over 17 days
after different treatments. As it has been established, ami-
fostine  treatment 30 min  prior to TBI protected the mice
against apparent weight loss; thus, no signiﬁcant weight
difference was observed between this group and the non-
irradiated control group. We also observed that the mice
receiving nonlethal 7 Gy TBI started losing weight 9 days
after  irradiation, and the loss sustained during the subse-
quent  days until the end of the experiment was  a maximum
of  approximately 7% of the pre-TBI value. However, we
unexpectedly observed a rapid weight decrease at 9 days
after  TBI in the group of mice administered quercetin.
Although the loss slowed 13 days after irradiation, the max-
imum  decrease reached up to 17% of the pre-treatment
value; one death was observed in this group on day 17 just
prior  to the experiment being terminated.
3.2. Development and optimization of qPCR
To reliably detect the possible differences in mtDNAcn
in bone marrow in the different groups, we  ﬁrst optimized
our  qPCR conditions using MTRNR1 (12S rRNA)-speciﬁc
and 18S rRNA-speciﬁc primers and preliminarily operat-
ing  the conventional PCR and qPCR. When we  ran the PCR
products, which were generated with a normal control
sample DNA template by the optimized conventional PCR,
R. Chen et al. / Toxicology Reports 1 (2014) 450–458 453
Fig. 2. Normal sample proﬁle for mtDNA and nDNA products. In panel A, PCR conditions were optimized to produce amplicons of different sizes and
intensities  for 12SmtDNA (177 bp, lane 1) and 18S nDNA (219 bp, lane 2), where the same volume of PCR solutions were loaded in the gel. Panels B and
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e found that the intensity of the MTRNR1 (12S rRNA)-
erived band was slightly lighter than that of the 18S
RNA-derived band in 4% agarose gel when the equal vol-
me  of PCR product solution was directly loaded, whereas
he  size of the former was 177 bp and the latter was 219 bp,
espectively (Fig. 2A). Correspondingly, the Ct values that
ere  presented in the qPCR ampliﬁcation curve for the
ame  sample DNA template (Fig. 2B) were also lower for
he  12S rRNA-derived amplicons than for the 18S rRNA-
erived amplicons, indicating that the copy number for 18S
RNA  gene was marginally higher than that of the mtDNA in
he  ICR bone marrow tissues. In addition, as shown in the
ccompanying melt curves (Fig. 2C), the expected single,
arrow peaks indicate that the mtDNA-derived and nDNA-
erived  PCR products in our qPCR system were sufﬁciently
ure and speciﬁc.
To  detect the expression levels of the POLG, POLG2, and
FAM  genes in the bone marrow tissues, we also opti-
ized our qPCR conditions using the primer sets speciﬁc
o  each of the 3 genes. Although we initially experienced
 few inferior primer sets that produced multiple peaks
n  the melt curves, we found good conditions by con-
tructing new primer sets. As shown in Fig. 3A–F, the
nalized conditions generated amplicons that presented
ood ampliﬁcation and melt curves; thus, they were used in
he  ﬁnal assay to quantitatively reveal the transcriptional
ifferences between each of the 3 genes and ACTB (the
nternal control gene). The ampliﬁcation curves for each
ene  showed the typical two phases – an exponential phase
ollowed by a plateau phase. The corresponding melt curves
or  the POLG, POLG2, and ACTB genes exhibited single and
arrow  peaks, which are the typical features of sufﬁciently
ure and speciﬁc PCR products. Although the melt curve
or  the TFAM gene had an additional smaller peak befored melt-curves with (a) and (b) denoting the qPCR product of nDNA and
the  gene-speciﬁc peak, this was likely due to the forma-
tion  of primer–dimer. The endpoint calculation, which was
performed based on the Ct values, was  not affected.
As the above results conﬁrmed that the qPCR conditions
developed were reliable, these conditions were used for
subsequent determinations.
3.3.  Effect of quercetin on mtDNA copy number
Fig. 4 shows the effects of quercetin treatment on mtD-
NAcn in bone marrow. Although the mtDNAcn in the bone
marrow  of the TBI group was higher than the nonirradiated
normal controls, it did not change signiﬁcantly in the group
treated  with 7 Gy TBI and quercetin (100 mg/kg) relative to
the  control. These results indicate that quercetin inhibited
the  radiation-stimulated increase of mtDNAcn.
3.4. Expression levels of target genes involved in mtDNA
ampliﬁcation
The transcription levels of POLG, POLG2, and TFAM in
bone  marrow tissues were measured with our optimized
qPCR using the gene-speciﬁc primer sets and the synthe-
sized cDNA templates. The results showed that in the TBI
group  POLG expression decreased markedly, whereas TFAM
expression  increased signiﬁcantly up to 4 fold compared to
the  nonirradiated control group. These changes were also
observed in the group treated with quercetin after TBI; the
changes  were even more dramatic than those observed in
the  TBI group, with up to a 6-fold increase observed for the
expression of the TFAM gene. No difference was  found in
POLG2  expression among the 3 groups (Fig. 5A–C).
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3 target
reﬂect th
urve prFig. 3. Representative reverse transcription qPCR (RT-qPCR) proﬁles of 
bone  marrow samples were determined under the optimal conditions to 
in  this ﬁgure denote the acquired corresponding ampliﬁcation and melt c
4. Discussion
Although previous studies have reported that radiation
induces an increase in mtDNAcn [13,14], to the best of
our  knowledge we are the ﬁrst to report that quercetin
inhibits the radiation-induced increase of mtDNAcn, which
results  from decreased POLG expression and the over-
expression of TFAM. Quercetin is widely consumed as
a  dietary supplement and has been studied for several
decades. Unfortunately, most of the literature focuses on
its  beneﬁcial health properties, and its potentially harm-
ful  effects have been understudied or largely ignored [1],
inevitably raising potential health concerns.
The beneﬁcial health effects of quercetin are believed
to be due to its strong antioxidative and free radical scav-
enging properties [20,21]. Such activities are largely a
function  of its chemical structure, which has been shown
to  contain all the structural elements characteristic of an
effective  antioxidant [20,22]. However, when quercetin
exerts its antioxidant effect, it may  be converted into
potentially harmful oxidation products or subjected to genes. The mRNA amounts transcribed from POLG, POLG2, and TFAM in
e expression levels of these genes. Each pair of panels (A/B, C/D, and E/F)
oﬁling for detecting POLG, POLG2, and TFAM genes, respectively.
in  vitro oxidative degradation, resulting in the formation
of  an ortho-quinone and the subsequent production of
ROS,  such as superoxide and hydrogen peroxide (H2O2)
[23].  The resultant prooxidant properties of quercetin are
responsible for its in vitro mutagenic and cytotoxic effects
[24,25]. Whether quercetin exerts antioxidant and prooxi-
dant  effects largely relates to its dose in a given biological
system [26] and can be revealed by determining changes in
the  level of oxidative stress in the system when quercetin is
added  at different doses. The combination of ROS level and
endogenous antioxidant protective activity as well as the
repair  or removal rate of the oxidized molecular targets,
including nucleic acids, proteins, and lipids, in a system
determine the level of oxidative stress. This stress can be
detected  by several available approaches [27,28].
Mitochondrial DNA replication is reliant on nuclear-
encoded transcription and replication factors that are
translocated to the mitochondria. It is well established
that heterotrimeric Pol and Tfam are crucial for mtDNA
replication [12,29]. The Pol holoenzyme is composed of a
single  catalytic subunit encoded by the POLG gene and a
R. Chen et al. / Toxicology Repo
Fig. 4. Effect of quercetin on mtDNAcn. Alterations in mtDNAcn are shown
with the data points denoting the mean ± SE of 6 mice per group. 
indicates a signiﬁcant difference in the average mtDNAcn between the
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oonirradiated normal control and each of the groups exposed to TBI alone
nd  to quercetin after TBI; # indicates a signiﬁcant difference in the aver-
ge  mtDNAcn between the two treatment groups.
omodimeric accessory subunit encoded by the POLG2
ene. The catalytic subunit possesses DNA polymerase
′–5′ exonuclease and 5′ deoxyribose phosphate lyase
ctivities that are responsible for mtDNA replication and
epair,  whereas the accessory subunit is a DNA-binding fac-
or  that confers high processivity on the protein complex
y  increasing its afﬁnity to DNA, which is responsible for
nhancing DNA binding and promoting processivity of DNA
ynthesis.  Tfam is another key factor in regulating mtDNA
mpliﬁcation and mitochondrial biogenesis [12,29]. Sev-
ral  studies have reported that the increase in mtDNAcn
s associated with upregulated TFAM expression and that
FAM  knockdown inhibits the enhancement of relative
tDNAcn [12,30]. Others have also reported that POLG
omozygous knockout in mice produces severe mtDNA
epletion and respiratory-chain deﬁciency and that muta-
ions  in POLG and POLG2 are associated with a variety of
linical  features [31,32].
Research  has well documented that mitochondria are
he  major intracellular sources and primary targets of
OS  [33–35]. Each human cell contains between several
undred and over a thousand mitochondria with each
arrying 2–10 copies of mtDNA. Mitochondrial DNAcn
s  correlated with the size and number of mitochon-
ria, which have been shown to change under different
nergy demands and physiological conditions. Due to
he  elevated free radical production following radiation
xposure and the close relationship between mitochon-
ria and ROS metabolism, mtDNA is more susceptible to
adiation  damage [35]. Radiation-induced mtDNA alter-
tions  are exhibited through mtDNAcn changes and other
amage,  such as mutation and depletion. As mtDNA
as few repair mechanisms, mitochondrial function is
reserved primarily by increasing mtDNAcn after irradi-
tion.  This notion is supported by our present data and
ther  studies [13,36–39], which indicate that enhanced
tDNA replication and the resulting elevation of mtD-
Acn  after irradiation or elevation in the intracellular level
f  ROS may  be radioprotective mechanisms or the resultrts 1 (2014) 450–458 455
of  the feedback response that compensates for defective
mitochondria in cells. The molecular events responsible for
this  radioprotection or feedback response may  be related
to  the coordinated alterations of mitochondrial membrane
potential and protein synthesis in cytoplasm [37]. Recently,
another study demonstrated that POLG is expressed at nor-
mal  levels in cells lacking mtDNA, suggesting that POLG
level  is not responsive or parallel to the abundance of
mtDNA in a cell [38]. This may  explain in part why the
mtDNAcn was  increased in mice exposed to only TBI,
whereas the expression of POLG was reduced in our present
study.
While  an oxidative stress-induced increase in mtDNAcn
may  compensate for the decline of mitochondrial respira-
tory  function, ROS are also generated from the increased
mitochondria in the affected cells. These ROS cause more
oxidative damage to mitochondria and other intracellu-
lar constituents, including DNA, RNA, proteins, and lipids,
and  consequently lead the cell to enter the process of
senescence or apoptosis [40]. This scenario of oxidative
stress response plays two  roles in the affected cells. On
one  hand, it stimulates mitochondrial proliferation to sup-
ply  the energy needs for cell survival; on the other hand,
it  causes excess ROS production and further oxidative
damage, thereby initiating cell death. The outcome of
this  increase in mitochondrial abundance and mtDNAcn
is  dependent on the level of oxidative stress, the capacity
of  the intracellular antioxidant system, and the quality of
mitochondria and mtDNA. When cells have higher antiox-
idant  capacity and good quality mitochondria and mtDNA,
the  response to mild oxidative stress will lead to an increase
in  the abundance of mitochondria and mtDNA molecules.
However, a compromise in the capacity of the antioxidant
system leads to an increase in defective mitochondria and
mutated  mtDNA, which in turn leads to an increase in ROS
production and oxidative damage. Once beyond a certain
threshold, mitochondria drive the cell into an irreversible
cell death process. Studies have extensively documented
the complicated scenario of mitochondrial functions under
oxidative stress [33–39]. While we  acknowledge that we
did  not conduct relevant measurements in our present
study, a wealth of literature supports our presumption
that oxidative stress contributes to our current observa-
tions. We  not only observed an increase in mtDNAcn and a
decrease  in POLG expression in the TBI mice but also found
that  mice gavaged with quercetin after TBI presented with
poor  overall health status (matted fur and up to17% loss of
body  weight) and a pronounced reduction in average mtD-
NAcn  relative to the TBI-only group. These results, which
potentially represent an adverse effect resulting from the
quercetin treatment, were contrary to what we predicted
at  the beginning of the study. This outcome might be
attributable to the following: (1) the repressed expression
of  the POLG gene resulted in the decline of mitochondrial
biogenesis and energy production; (2) the more affected
cells  underwent a gradual yet irreversible cell death pro-
cess  due to the other potential toxicities of quercetin, such
as  its prooxidant activity, apoptosis-inducing properties,
and interactions with some metabolizing enzymes [1];
and/or  (3) the approximately 6-fold overexpression of the
TFAM  gene contributed to the repression of the mtDNAcn
456 R. Chen et al. / Toxicology Reports 1 (2014) 450–458
e expres
icates aFig. 5. Effect of quercetin on the expression of POLG, POLG2, and TFAM. Th
with  the data points representing the mean ± SE of 6 mice per group. * ind
and the overall toxicity observed in our study. Previous
studies indicated that the increased Tfam:mtDNA ratio may
inhibit  mitochondrial transcription [41] and that the over-
expression of TFAM decreases the amount of a D-loop form
of  mtDNA in cells [42]. These studies support our notion
that  TFAM overexpression could also cause the observed
potential toxicity of quercetin.
Our  study further demonstrated that the expression of
POLG2  did not change markedly in the 2 treated groups
relative to the normal control. This ﬁnding indicates
that radiation-induced oxidative stress can preferentially
inhibit the transcription of POLG while maintaining the
transcription of POLG2. This ﬁnding is in keeping with the
in  vitro observation that the catalytic subunit Polg is a tar-
get  of oxidative stress and that this oxidation inactivates
the subunit, whereas the function of the accessory subunit
Polg2  is not compromised when it is oxidized [43]. In addi-
tion,  we observed statistically insigniﬁcant differences in
the  expression of POLG and POLG2 between the 2 treatedsion levels of POLG (A), POLG2 (B), and TFAM (C) in the 3 groups are shown
 signiﬁcant difference between the normal control and treatment groups.
groups although the expression of POLG was seemingly
reduced more in the mice exposed to quercetin after TBI,
indicating that the effects of quercetin on the expression
of the 2 genes were undetectable. Taken together, these
results suggest that the responses of the POLG, POLG2, and
TFAM  genes to oxidative stress and quercetin treatment are
complex.  Further studies are needed to clarify the detailed
mechanisms that are involved.
Notably,  quercetin was administered to mice in saline
in  our present study. Although quercetin lacks easy solu-
bility  in aqueous solutions [44,45], its absorption after oral
supplementation ranges from 0 to over 50% of the admin-
istered dose in human or the total oral bioavailability is
17%  of the applied dose in pigs [46]. We  acknowledge that,
due  to the lack of direct measurements, we do not know
how  much quercetin is actually absorbed into the blood
and  delivered to the bone marrow of the mice in our study.
As  such, our comparisons are likely to be more qualitative
than quantitative. With regard to the scientiﬁc basis for the
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uercetin dose used in the present study, previous animal
tudies used oral treatments of quercetin at doses ran-
ing  from 10 to 3000 mg/kg body weight [47,48]. Moreover,
nimal toxicity studies have demonstrated that quercetin
s  tolerated at oral dose levels exceeding its oral LD50
alue 160 mg/kg body weight by several fold [49]. Fur-
her,  since curcumin or vesveratrol, two natural potential
ntioxidants tested simultaneously in the present study,
as  orally given to mice at 100 mg/kg body weight in sev-
ral  earlier studies [50,51], the same dose of quercetin
100 mg/kg body weight) was thus used in the present
tudy in order to make comparisons. In addition, we  found
iscrepancies between the data presented in this study and
n  an earlier study [52]. Previously, we observed that the
atio  of mtDNA:nDNA was clearly higher when the small
owel  DNA of nonirradiated male BALB/c mice was  ampli-
ed  with the 2 sets of identical primers, as evidenced by the
ifference  in the resulting band intensity in 4% gel; how-
ver,  this result is contrary to what we found in this most
ecent  study (Fig. 2A). Moreover, another study showed
hat Polg protein levels were signiﬁcantly increased in the
ntestines of mice receiving 5 Gy TBI, whereas the Tfam pro-
ein  levels were clearly decreased [39]. This result is also
ontrary to our present data. We  propose that differences
n  animal species and tissue types or other variables might
ccount  for our most recent ﬁndings. Further studies are
arranted.
In  summary, our results demonstrate that quercetin can
epress  mtDNAcn via selectively affecting the expression
evels of POLG and TFAM genes, whereas it has no appar-
nt  effect on POLG2 gene expression. This ﬁnding reveals
hat  quercetin not only affects mitochondrial anabolism
ut also differentially affects the expression levels of the
enes  that jointly encode the same mitochondria-speciﬁc
olymerase. These effects should be taken into consider-
tion in drug development programs for quercetin. Further
tudies  are required to determine if quercetin interacts
ith other effect or molecules to achieve deeper insight
nto its in vivo biological activities.
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